Literature DB >> 24229755

Female reproductive life cycle and hormones: methodology to improve clinical trials.

Marlene P Freeman1, Rosemary Walker, Thomas P Laughren, Karen K Miller, Maurizio Fava.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24229755      PMCID： PMC4096821          DOI： 10.4088/JCP.13com08742

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  25 in total

Review 1.  Antidepressant effects of estrogens: a basic approximation.

Authors:  Erika Estrada-Camarena; Carolina López-Rubalcava; Nelly Vega-Rivera; Soledad Récamier-Carballo; Alonso Fernández-Guasti
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

Review 2.  Effect of estrogen-serotonin interactions on mood and cognition.

Authors:  Zenab Amin; Turhan Canli; C Neill Epperson
Journal:  Behav Cogn Neurosci Rev       Date:  2005-03

3.  Depression in women: windows of vulnerability and new insights into the link between estrogen and serotonin.

Authors:  Sonali Lokuge; Benicio N Frey; Jane A Foster; Claudio N Soares; Meir Steiner
Journal:  J Clin Psychiatry       Date:  2011-11       Impact factor: 4.384

4.  Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.

Authors:  C N Soares; O P Almeida; H Joffe; L S Cohen
Journal:  Arch Gen Psychiatry       Date:  2001-06

Review 5.  Serotonin and female psychopathology.

Authors:  Elise Hall; Meir Steiner
Journal:  Womens Health (Lond)       Date:  2013-01

Review 6.  Polymorphisms of estrogen receptors and risk of depression: therapeutic implications.

Authors:  Joanne Ryan; Marie-Laure Ancelin
Journal:  Drugs       Date:  2012-09-10       Impact factor: 9.546

7.  The clinical relevance of self-reported premenstrual worsening of depressive symptoms in the management of depressed outpatients: a STAR*D report.

Authors:  Charlotte L Haley; Sharon C Sung; A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; James F Luther; Susan G Kornstein
Journal:  J Womens Health (Larchmt)       Date:  2013-03       Impact factor: 2.681

8.  The epidemiology of depression. An update on sex differences in rates.

Authors:  M M Weissman; P J Leaf; C E Holzer; J K Myers; G L Tischler
Journal:  J Affect Disord       Date:  1984-12       Impact factor: 4.839

Review 9.  Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties.

Authors:  R Rupprecht
Journal:  Psychoneuroendocrinology       Date:  2003-02       Impact factor: 4.905

10.  Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study.

Authors:  Susan G Kornstein; Marisa Toups; A John Rush; Stephen R Wisniewski; Michael E Thase; James Luther; Diane Warden; Maurizio Fava; Madhukar H Trivedi
Journal:  J Womens Health (Larchmt)       Date:  2013-02       Impact factor: 2.681
View more
  2 in total

1.  Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression.

Authors:  Marlene P Freeman; George I Papakostas; Bettina Hoeppner; Erica Mazzone; Heidi Judge; Cristina Cusin; Sanjay Mathew; Gerard Sanacora; Dan Iosifescu; Charles DeBattista; Madhukar H Trivedi; Maurizio Fava
Journal:  J Psychiatr Res       Date:  2019-01-08       Impact factor: 4.791

2.  Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials.

Authors:  Robyn R Jones; Marlene P Freeman; Susan G Kornstein; Kimberly Cooper; Ella J Daly; Carla M Canuso; Susan Nicholson
Journal:  Arch Womens Ment Health       Date:  2022-01-01       Impact factor: 3.633
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.